/A randomized, double-blind, placebo-controlled phase 2b trial using the novel predictive genetic biomarker DGM4 for liafensine in treatment-resistant depression
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)